节点文献

JNK抑制剂对D-氨基葡萄糖衍生物诱导Eca-109细胞Caspase-3活化的影响

The Effect of JNK Inhibitor on Caspase-3 Activation of the Human Esophageal Cancer Cell Line Eca-109 induced by the Derivative of D-aminoglucose

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 强占荣吴静杨国栋周永宁姬瑞李娟王爱勤薛群基

【Author】 Qiang Zhanrong Wu Jing Yang Guodong et al Department of Gastroenterology, the First Affiliated Hospital of Lanzhou University, Lanzhou

【机构】 兰州大学第一医院消化科兰州大学第一医院中心实验室中国医学科学院兰州化学物理研究所中国医学科学院兰州化学物理研究所 兰州市730000兰州市730000

【摘要】 目的:观察特异性c-Jun氨基末端激酶(JNK)抑制剂SP600125对D-氨基葡萄糖衍生物(COPADG)诱导的Eca-109细胞Caspase-3激活及细胞凋亡的影响,并探讨COPADG诱导Eca-109细胞凋亡的潜在分子机制。方法:体外培养Eca-109细胞,以COPADG及SP600125与细胞作用,细胞间接免疫荧光染色观察P-JNK蛋白表达的改变,流式细胞术检测细胞凋亡率及Caspase-3活性的变化。结果:经SP600125处理后,COPADG诱导的Eca-109细胞P-JNK蛋白表达明显减弱,凋亡率明显减低,Caspase-3活性显著下调,与COPADG单作用组之间有显著性差异。结论:SP600125能够显著抑制COPADG诱导Eca-109细胞Caspase-3激活以及COPADG诱导Eca-109细胞凋亡,并间接证明JNK信号转导通路在COPADG诱导Eca-109细胞凋亡过程中发挥着重要作用。

【Abstract】 Objective: To explore the effect of SP600125, a specific c-jun NH2 terminal protein kinase (JNK) inhibitor, on apoptosis and Caspase-3 activation of the human esophageal cancer cell line Eca-109 induced by the COPADG. and to discuss the possible molecular mechanisms in COPADG-induced apoptosis. Methods: The human esophageal caner cell line Eca-109 was cultured in vitro and was incubated with SP600125 and COPADG. The Changes in the expression of P-JNK was determined with immunofluorescence cytochemistry, apoptosis rate and Caspase-3 activity was analyzed using flow cytometry. Results: SP600125 remarkably reduced the expression of P-JNK and decreased apoptosis rate as well as Caspase-3 activity in the human esophageal cancer cell line Eca-109 compared with those treated with COPADG only. Conclusion: SP600125 has a significant inhibitory action on Caspase-3 activation and indirectly demonstrate a significant protective effect on the COPADG-induced apoptosis in Eca-109. Thus, JNK signaling pathway may play an important role in apoptosis of Eca-109 induced by the COPADG.

【基金】 “西部之光”基金资助(编号:200524)
  • 【文献出处】 中国肿瘤临床 ,Chinese Journal of Clinical Oncology , 编辑部邮箱 ,2006年07期
  • 【分类号】R735.1
  • 【被引频次】9
  • 【下载频次】296
节点文献中: